Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers ...

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

Hundreds of foods are recalled by the FDA every year. Food recalls could fall into different categories, depending on how ...

The U.S. Food & Drug Administration has accepted Aptar Pharma's N-Sorb nitrosamine mitigation solution into its Emerging ...

Stock futures were modestly higher ahead of the release of the Federal Reserve's preferred measures of inflation, as major ...

Biomea Fusion has escaped from the full clinical hold imposed by the FDA. | Biomea Fusion has escaped from the full clinical hold imposed by the FDA. After reviewing the data, the regulator has ...

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S.

Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.